IRADIMED CORP — Director's Dealing 2023

Dec 12, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2023-12-07

Reporting Person: ALLEN MONTY K (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-07	Common Stock	M	1036	—	Acquired	18250	Direct
2023-12-07	Common Stock	M	1750	—	Acquired	20000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-07	Restricted Stock Units	$	M	1036	Disposed		Common Stock (1036)	Direct
2023-12-07	Restricted Stock Units	$	M	1750	Disposed		Common Stock (1750)	Direct
2023-12-07	Restricted Stock Units	$	A	2393	Acquired		Common Stock (2393)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: On December 7, 2021, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F3: On December 7, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F4: On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.